Cargando…
Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD)
CASE SERIES: This is retrospective case series involving 72 patients who presented with symptoms associated with inability to burp. The following symptoms was described by almost all the patients; retrosternal pain after eating or drinking, bloating feeling in the stomach, gurgling noise in the thro...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553696/ https://www.ncbi.nlm.nih.gov/pubmed/33893849 http://dx.doi.org/10.1007/s00405-021-06790-w |
_version_ | 1784591632458317824 |
---|---|
author | Karagama, Yakubu |
author_facet | Karagama, Yakubu |
author_sort | Karagama, Yakubu |
collection | PubMed |
description | CASE SERIES: This is retrospective case series involving 72 patients who presented with symptoms associated with inability to burp. The following symptoms was described by almost all the patients; retrosternal pain after eating or drinking, bloating feeling in the stomach, gurgling noise in the throat, excessive flatulence. These symptoms are worse with fizzy/carbonated drinks and beer. A full clinical history and examination plus endoscopic and in some cases barium a swallow radiological investigation was done. PROCEDURE: The surgery was performed under a general anaesthesia for all cases. Suspension pharyngoscopy in supine position using a Weerda diverticuloscope to identify the cricopharyngeal bar muscle. High dose of botulinum toxin A (botox) 100 iu was injected into the cricopharynxgeus muscle under a general anaesthesia. RESULTS: A total of 72 patients were diagnosed and undergone surgery between November 2016 and December 2020. There were 50 male and 22 female patients. Their average age was 30 (range 18–68 years old). All patients were able to burp again within first 4 weeks of the injection. This persisted even after the Botox worn off beyond the 3 months in 96% of cases. The average follow-up was 24 months post injection with longest follow-up 48 months (range 1–48 months). CONCLUSION: The author reported a new condition of inability to burp due to failure of the cricopharyngeal sphincter to relax spontaneously and outcome of treatment using botulinum toxin A injection into the cricopharyngeus muscle. It is expected that the paralysing action of botulinum toxin injection last approximately 3 months. However, this group of patients seem to be cured even after the effect of the botox is worn off. The author therefore postulated that there might me some neural dysfunction that inhibits the brain to send signals to the cricopharyngeal sphincter to initiate burping. Once burping is re-established with the help of botox injection, spontaneous burping seems to occur and sustained even after the botox is worn off. |
format | Online Article Text |
id | pubmed-8553696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85536962021-11-04 Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD) Karagama, Yakubu Eur Arch Otorhinolaryngol Short Communication CASE SERIES: This is retrospective case series involving 72 patients who presented with symptoms associated with inability to burp. The following symptoms was described by almost all the patients; retrosternal pain after eating or drinking, bloating feeling in the stomach, gurgling noise in the throat, excessive flatulence. These symptoms are worse with fizzy/carbonated drinks and beer. A full clinical history and examination plus endoscopic and in some cases barium a swallow radiological investigation was done. PROCEDURE: The surgery was performed under a general anaesthesia for all cases. Suspension pharyngoscopy in supine position using a Weerda diverticuloscope to identify the cricopharyngeal bar muscle. High dose of botulinum toxin A (botox) 100 iu was injected into the cricopharynxgeus muscle under a general anaesthesia. RESULTS: A total of 72 patients were diagnosed and undergone surgery between November 2016 and December 2020. There were 50 male and 22 female patients. Their average age was 30 (range 18–68 years old). All patients were able to burp again within first 4 weeks of the injection. This persisted even after the Botox worn off beyond the 3 months in 96% of cases. The average follow-up was 24 months post injection with longest follow-up 48 months (range 1–48 months). CONCLUSION: The author reported a new condition of inability to burp due to failure of the cricopharyngeal sphincter to relax spontaneously and outcome of treatment using botulinum toxin A injection into the cricopharyngeus muscle. It is expected that the paralysing action of botulinum toxin injection last approximately 3 months. However, this group of patients seem to be cured even after the effect of the botox is worn off. The author therefore postulated that there might me some neural dysfunction that inhibits the brain to send signals to the cricopharyngeal sphincter to initiate burping. Once burping is re-established with the help of botox injection, spontaneous burping seems to occur and sustained even after the botox is worn off. Springer Berlin Heidelberg 2021-04-24 2021 /pmc/articles/PMC8553696/ /pubmed/33893849 http://dx.doi.org/10.1007/s00405-021-06790-w Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Short Communication Karagama, Yakubu Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD) |
title | Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD) |
title_full | Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD) |
title_fullStr | Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD) |
title_full_unstemmed | Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD) |
title_short | Abelchia: inability to belch/burp—a new disorder? Retrograde cricopharyngeal dysfunction (RCPD) |
title_sort | abelchia: inability to belch/burp—a new disorder? retrograde cricopharyngeal dysfunction (rcpd) |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553696/ https://www.ncbi.nlm.nih.gov/pubmed/33893849 http://dx.doi.org/10.1007/s00405-021-06790-w |
work_keys_str_mv | AT karagamayakubu abelchiainabilitytobelchburpanewdisorderretrogradecricopharyngealdysfunctionrcpd |